Your browser doesn't support javascript.
loading
Absence of Relationship Between Crohn's Disease Activity Index or C-Reactive Protein and Infliximab Exposure Calls for Objective Crohn's Disease Activity Measures for the Evaluation of Treatment Effects at Treatment Failure.
Edlund, Helena; Grisic, Ana-Marija; Steenholdt, Casper; Ainsworth, Mark A; Brynskov, Jørn; Huisinga, Wilhelm; Kloft, Charlotte.
Affiliation
  • Edlund H; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin.
  • Grisic AM; Graduate Research Training Program PharMetrX, Berlin and Potsdam, Germany.
  • Steenholdt C; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin.
  • Ainsworth MA; Graduate Research Training Program PharMetrX, Berlin and Potsdam, Germany.
  • Brynskov J; Department of Gastroenterology, Herlev Hospital, Herlev, Denmark.
  • Huisinga W; Department of Gastroenterology, Herlev Hospital, Herlev, Denmark.
  • Kloft C; Department of Gastroenterology, Herlev Hospital, Herlev, Denmark.
Ther Drug Monit ; 41(2): 235-242, 2019 04.
Article in En | MEDLINE | ID: mdl-30883516

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: C-Reactive Protein / Crohn Disease / Infliximab Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Ther Drug Monit Year: 2019 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: C-Reactive Protein / Crohn Disease / Infliximab Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Ther Drug Monit Year: 2019 Document type: Article